Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2026-01-09 @ 6:20 AM
Study NCT ID:
NCT00295503
Status:
COMPLETED
Last Update Posted:
2020-10-20
First Post:
2006-02-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
Sponsor:
University of Texas Southwestern Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AVF3442S
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None